About Us

Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
My Watchlist
Indicators
Local Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CNS Pharmaceuticals, Inc. - Common Stock (NQ:CNSP)

6.375 -0.345 (-5.13%)
Streaming Delayed Price Updated: 12:13 PM EST, Jan 22, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about CNS Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
21 22 Next >
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) to Present Promising Glioblastoma Data at Brain Tumor Biotech Summit
Via Investor Brand Network
News headline image
CNS Pharmaceuticals' Chief Medical Officer, Sandra Silberman, MD, PhD to Present at the 2025 Brain Tumor Biotech Summit
Via ACCESS Newswire
Hundreds Sue Pfizer Over Birth Control Jabs Linked to Brain Tumors
Via Investor Brand Network
Topics Lawsuit
Study Finds That Kids, Young People Wait Longer to Receive a Cancer Diagnosis
Via Investor Brand Network
Experts Say New Test for Brain Tumors is a Game-Changer
Via Investor Brand Network
News headline image
CNS Pharmaceuticals Reports Full Year 2024 Financial Results
Via ACCESS Newswire
BioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Reports Q1 Loss, Highlights Progress on TPI 287 for Brain Cancer
Via Investor Brand Network
News headline image
CNS Pharmaceuticals Stock Declines On Wider Q1 Loss: But Retail Stays Unmoved ↗
The company intends to commence the phase 2 study of its lead program, TPI 287, to treat Glioblastoma Multiforme (GBM) by year-end. 
Via Stocktwits
News headline image
CNS Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Corporate Update
Via ACCESS Newswire
Simple Hand Motion Test Could Reveal Undetected Brain Tumor
Via Investor Brand Network
BioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Prices $5 Million Public Offering with Institutional Investor
Via Investor Brand Network
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
 
Via Benzinga
News headline image
There are notable gap-ups and gap-downs in today's session. ↗
Let's delve into the US markets on Tuesday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks. 
Via Chartmill
News headline image
Which stocks are moving before the opening bell on Tuesday? ↗
Let's have a look at what is happening on the US markets before the opening bell on Tuesday. Below you can find the top gainers and losers in today's pre-market session. 
Via Chartmill
News headline image
CNS Pharmaceuticals Announces Pricing of $5 Million Public Offering Priced At-The-Market Under Nasdaq Rules
Via ACCESS Newswire
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Secures Orphan Drug Designation Transfer for TPI 287 in Brain Cancer Indications
Via Investor Brand Network
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
Via Benzinga
News headline image
CNS Pharmaceuticals Acquires Orphan Drug Designation for Novel, Late Stage Abeotaxane, TPI 287
Via ACCESS Newswire
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
 
Via Benzinga
Study Reveals Early Development of Pediatric Brain Tumors in Specialized Nerve Cells
Via Investor Brand Network
AI Can Predict the Recurrence of Brain Tumors in Kids, Study Finds
Via Investor Brand Network
Topics Artificial Intelligence
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
 
Via Benzinga
Study Identifies Key Enzyme That Could Be Targeted to Fight Brain Cancers
Via Investor Brand Network
The Global Market for Brain Tumor Treatments Will Reach $7.15 Billion by 2035
Via Investor Brand Network
News headline image
Top stock movements in today's session. ↗
Here are the top movers in Tuesday's session, showcasing the stocks with significant price changes. 
Via Chartmill
News headline image
The market is filled with gapping stocks in Tuesday's session. ↗
There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Tuesday. 
Via Chartmill
News headline image
Study Uncovers Drivers of Brain Tumor Growth, Could Open New Treatment Approaches
Via Investor Brand Network
News headline image
Pitt Researchers Develop Diagnostic Tool for Profiling Pediatric Brain Cancers
Via Investor Brand Network
News headline image
InvestorNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Advances TPI 287 for GBM, Ends 2024 with Strong Cash Position
Via Investor Brand Network
Firefighters Have an Increased Chance of Having Gene Mutations Associated with Brain Cancer, Study Says
Via Investor Brand Network
< Previous 1 2 3 4 5 6 7 8 9
...
21 22 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.